Skip to main content
AppaltiWatch

PROCEDURA NEGOZIATA SENZA PREVIA PUBBLICAZIONE DEL BANDO, PER LA FORNITURA PER UN PERIODO DI 48 MESI, DI FARMACI DELLA DITTA NOVARTIS FARMA SPA.

AZIENDA SANITARIA DELL'ALTO ADIGE - SUEDTIROLER SANITAETSBETRIEB

CIG 78476662DAVerify on ANACTrentino-South TyrolGoods / suppliesCompetitive dialogueCPV 33662000-8Risk signal — not an accusation of crime.
At a glance
Key figures from open ANAC records for this contract.

Amount

€16,053,778

Award date

13 Jun 2019

Bids

1

Published

26 Mar 2019

Estimated tender value

€19,633,633

Sector (CPV)

MEDICINALI PER GLI ORGANI SENSORIALI
Timeline

  1. Publication / start of procedure

    26 Mar 2019

    Step completed

  2. Time to submit bids

    26 Apr 2019

    31 days between opening and deadline

    Step completed

  3. Award

    13 Jun 2019

    Step completed

  4. Contract signed

    31 Dec 2019

In plain language

These are automated checks on public data. They help you decide what to look into — they are not criminal findings.

This contract triggered 5 pattern(s) worth a closer look:

Low competition · Same supplier often

Contracting authority (buyer)
AZIENDA SANITARIA DELL'ALTO ADIGE - SUEDTIROLER SANITAETSBETRIEB

Trentino-South Tyrol · More tenders in this area

AUSA code: 0000171929

BOLZANO .BOZEN.

Authority profile
Awarded to (suppliers)
1 award line(s) on record.
SupplierRegionAmountAward dateStatus
NOVARTIS FARMA SPA—€16,053,77813 Jun 2019AGGIUDICATA
How do I verify this tender?

Loading actions…

Similar tenders in the same area

Loading comparison…

Sector comparison

Loading…

Amount vs category

Loading…

Citizen verifier notes
Share what you verified on official sources — not a verdict
How the score is built
Ruleset 2.0.0 · 6 Jul 2026
Source data & verification

ANAC BDNCP — dati tabellari

Verify on ANAC

Ingested: 6 Jul 2026

Release: 20260501-cig_csv.csv

Days to submit bids: 31

PROCEDURA NEGOZIATA SENZA PREVIA PUBBLICAZIONE DEL BANDO, PER LA FORNITURA PER UN PERIODO DI 48 MESI, DI FARMACI DELLA DITTA NOVARTIS FARMA SPA. — AppaltiWatch